Apex Mobile Clinical Research

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Obesity4 trials
• Familial hypercholesterolaemia1 trial
• Fatty liver disease (MASLD/MASH)1 trial
• Type 2 diabetes1 trial

Phase

• Phase 25 trials
• Phase 31 trial

Status

• Completed5 trials
• Active, not recruiting1 trial

Lead sponsor

• Hoffmann-La Roche2 trials
• Carmot Therapeutics, Inc.1 trial
• GlaxoSmithKline1 trial
• NewAmsterdam Pharma1 trial
• Scholar Rock, Inc.1 trial

Running trials

• Recruiting

  A Study to Compare Different Doses of Tifeglipron (RO7795081) With Placebo or Semaglutide in People With Type 2 Diabetes

  NCT07112872· Phase 2· Hoffmann-La Roche· Source

Closed trials

• Completed

  A Study Evaluating the Effect of Daily Oral Tifeglipron (RO7795081) in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity

  NCT07081958· Phase 2· Hoffmann-La Roche· Source

• Completed

  A Study of Enicepatide (CT-388) in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity

  NCT06525935· Phase 2· Carmot Therapeutics, Inc.· Source

• Completed

  Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or Obese

  NCT06445075· Phase 2· Scholar Rock, Inc.· Source

• Completed

  Randomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies

  NCT05142722· Phase 3· NewAmsterdam Pharma· Source

• Completed

  A Study of BOS-580 in Obese Subjects at Risk for, or With Biopsy-confirmed, Nonalcoholic Steatohepatitis (NASH) With an Extension

  NCT04880031· Phase 2· GlaxoSmithKline· Source